StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Over-the-Counter Medicines by Year

Over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — International sales ($M) ($M)

Johnson & Johnson Over-the-Counter Medicines: $3,249M in FY2022, up 7.1% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2022
3,249
Period ended Jan 1, 2023
Change on a year earlier
+7.1%
3,034 in FY2021
History
7 years
Since FY2016
Sources
4
Documents cited below

Where the FY2022 figure comes from

Source: Form 10-K (filed 2023-02-16) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOver-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — International sales ($M) ($M)Year on yearSource
FY2022Jan 1, 20233,249+7.1%Form 10-K (filed 2023-02-16) ↗
FY2021Jan 2, 20223,034+9.9%Form 10-K (filed 2023-02-16) ↗
FY2020Jan 3, 20212,761+13.4%Form 10-K (filed 2023-02-16) ↗
FY2019Dec 29, 20192,434-2.0%Form 10-K (filed 2022-02-17) ↗
FY2018Dec 30, 20182,484+3.1%Form 10-K (filed 2021-02-22) ↗
FY2017Dec 31, 20172,410+4.7%Form 10-K (filed 2019-02-20) ↗
FY2016Jan 1, 20172,302–Form 10-K (filed 2019-02-20) ↗

Breakdown

What makes up over-the-Counter Medicines

Cite this data

StockData. (2026). Johnson & Johnson Over-the-Counter Medicines ($M), annual FY2016–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-otc-intl

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.